Similar articles

• The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.

  Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Balaguer F, Sempere L, Xicola RM, Bujanda L, Reñé JM, Clofent J, Bessa X, Morillas JD, Nicolás-Pérez D, Pons E, Payá A, Alenda C; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Jover R, et al. Eur J Cancer. 2009 Feb;45(3):365-73. doi: 10.1016/j.ejca.2008.07.016. Epub 2008 Aug 21. Eur J Cancer. 2009. PMID: 18722765
• Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?

  Kerr DJ, Midgley R. Kerr DJ, et al. J Clin Oncol. 2010 Jul 10;28(20):3210-2. doi: 10.1200/JCO.2010.28.9322. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498404 No abstract available.
• Predictive value of defective mismatch repair in adjuvant colon cancer.

  Atkins CD. Atkins CD. J Clin Oncol. 2010 Dec 10;28(35):e746; author reply e747. doi: 10.1200/JCO.2010.31.8824. Epub 2010 Nov 1. J Clin Oncol. 2010. PMID: 21041713 No abstract available.
• [The current status of adjuvant chemotherapy of colonic cancer].

  Takiuchi H. Takiuchi H. Gan To Kagaku Ryoho. 2009 Nov;36(11):1826-8. Gan To Kagaku Ryoho. 2009. PMID: 19999632 Review. Japanese. No abstract available.
• [Adjuvant treatment of carcinoma of the colon].

  Zaniboni A. Zaniboni A. Tumori. 2000 May-Jun;86(3 Suppl):S23-4. doi: 10.1177/03008916000863S107. Tumori. 2000. PMID: 10969611 Review. Italian. No abstract available.